1. Home
  2. MODD vs ELTX Comparison

MODD vs ELTX Comparison

Compare MODD & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MODD
  • ELTX
  • Stock Information
  • Founded
  • MODD 1998
  • ELTX 2011
  • Country
  • MODD United States
  • ELTX United States
  • Employees
  • MODD N/A
  • ELTX N/A
  • Industry
  • MODD Industrial Specialties
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MODD Health Care
  • ELTX Health Care
  • Exchange
  • MODD Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • MODD 46.8M
  • ELTX 54.6M
  • IPO Year
  • MODD N/A
  • ELTX 2021
  • Fundamental
  • Price
  • MODD $1.08
  • ELTX $8.54
  • Analyst Decision
  • MODD Buy
  • ELTX Strong Buy
  • Analyst Count
  • MODD 1
  • ELTX 3
  • Target Price
  • MODD $5.00
  • ELTX $9.50
  • AVG Volume (30 Days)
  • MODD 69.5K
  • ELTX 59.7K
  • Earning Date
  • MODD 02-13-2025
  • ELTX 03-28-2025
  • Dividend Yield
  • MODD N/A
  • ELTX N/A
  • EPS Growth
  • MODD N/A
  • ELTX N/A
  • EPS
  • MODD N/A
  • ELTX N/A
  • Revenue
  • MODD N/A
  • ELTX N/A
  • Revenue This Year
  • MODD N/A
  • ELTX N/A
  • Revenue Next Year
  • MODD N/A
  • ELTX N/A
  • P/E Ratio
  • MODD N/A
  • ELTX N/A
  • Revenue Growth
  • MODD N/A
  • ELTX N/A
  • 52 Week Low
  • MODD $1.07
  • ELTX $3.34
  • 52 Week High
  • MODD $2.65
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • MODD 27.02
  • ELTX 58.77
  • Support Level
  • MODD $1.08
  • ELTX $7.78
  • Resistance Level
  • MODD $1.28
  • ELTX $8.23
  • Average True Range (ATR)
  • MODD 0.07
  • ELTX 0.60
  • MACD
  • MODD -0.00
  • ELTX -0.15
  • Stochastic Oscillator
  • MODD 4.46
  • ELTX 55.14

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: